Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252928 · ClinicalTrials.gov registry record · NA
Health Impact Study of Aquatabs in Tamale, Ghana
A NA study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT00252928 is a NA study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 240 participants.
The verdict
NCT00252928, a NA study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.
Interventions
- OTHER Placebo
- OTHER Sodium dichloroisocyanurate (NaDCC) tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00252928
The ClinicalTrials.gov registry entry for NCT00252928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00252928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00252928 about?
NCT00252928 is a clinical study titled "Health Impact Study of Aquatabs in Tamale, Ghana". The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.
What is the current status of trial NCT00252928?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2006-07. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00252928?
The interventions under investigation include: Placebo (OTHER), Sodium dichloroisocyanurate (NaDCC) tablets (OTHER).
Who is sponsoring clinical trial NCT00252928?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.